Blake Anson

Affiliations: 
 
Google:
"Blake Anson"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Grimm FA, Blanchette A, House JS, et al. (2018) A human population-based organotypic in vitro model for cardiotoxicity screening. Altex
Millard D, Dang Q, Shi H, et al. (2018) Cross-Site Reliability of Human Induced Pluripotent Stem-Cell Derived Cardiomyocyte Based Safety Assays using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study. Toxicological Sciences : An Official Journal of the Society of Toxicology
Sirenko O, Grimm FA, Ryan KR, et al. (2017) In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Toxicology and Applied Pharmacology
Zamora V, Hortigon-Vinagre MP, Burton F, et al. (2017) Medium Through-put Electrophysiological and Inotropic Studies on iCell 2 hiPSC-Derived Cardiomyocytes Using the CellOPTIQ® Platform Journal of Pharmacological and Toxicological Methods. 88: 243
Carlson C, Hancock M, Thomson A, et al. (2017) Detection of Xenobiotic-Induced Hepatotoxicity in Human iPSC-Derived iCell Hepatocytes 2.0 Journal of Pharmacological and Toxicological Methods. 88: 236
Anson B, Feaster T, Jarecki B, et al. (2017) Advances in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Maintaining Validated Responses While Accelerating Workflows Journal of Pharmacological and Toxicological Methods. 88: 235
Drowley L, Koonce C, Peel S, et al. (2015) Human iPSC-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation. Stem Cells Translational Medicine
Jones D, Liu F, Anson B, et al. (2015) Loss of hERG 1b is arrhythmogenic in human cardiomyocytes Journal of Pharmacological and Toxicological Methods. 75: 166-167
Jones E, Carlson CB, Koonce C, et al. (2015) Human iPS Cell-Derived Cardiomyocytes Carrying MHC-R403Q Exhibit Aspects of Hypertrophic Cardiomyopathy in vitro Biophysical Journal. 108: 598a
Smith G, Cooper J, Hortigon-Vinagre M, et al. (2014) Discrimination power of optically recorded action potentials in cardiomyocytes derived from human induced pluripotent stem cells Journal of Pharmacological and Toxicological Methods. 70: 353
See more...